Document is current
Any future updates will be listed below
-
Authors
Zhao, Xiaoxuan
Xu, Mingxi
Hu, Xuemeng
Ding, Xiaolei
Zhang, Xian
Xu, Liye
Li, Li
Sun, Xiuhua
Song, Jincheng https://orcid.org/0000-0001-9263-4614
-
Funding
Funding for this research was provided by:
Dalian Science and Technology Bureau (19Z12001)
Dalian Science and Technology Innovation Fund (1911089)
National Natural Science Foundation of China (81970181, 82100205)
- License Information
-
More Information
Article History
Received: 8 August 2022
Accepted: 9 May 2023
First Online: 29 May 2023
Declarations
:
: All animal study protocols were approved by the Animal Welfare and Ethics Committee of The Second Affiliated Hospital of Dalian Medical University and performed in accordance with the ARRIVE guidelines. (No.2021005; Title: The study of miRNA-124 carried by exocrine body attenuates the resistance to adriamycin chemotherapy in diffuse large B cell lymphoma; Date of approval: March 3, 2021).
: Not applicable.
: The authors declare that they have no competing interests.
